Journal of Cancer Research and Therapeutics Close
 

Figure 6: Cytotoxicity study, inhibition rate of α-tocopherol-5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles and 5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles in squamous cell carcinoma-15 cells detected by methyl thiazolyl tetrazolium assay. (a) Inhibition rate of different dose-concentration-time (24, 48, 72 h) of 5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles on squamous cell carcinoma-15 cells. (b) Inhibition rate of different dose-concentration-time (24, 48, 72 h) of α-tocopherol-5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles on squamous cell carcinoma-15 cells

Figure 6: Cytotoxicity study, inhibition rate of α-tocopherol-5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles and 5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles in squamous cell carcinoma-15 cells detected by methyl thiazolyl tetrazolium assay. (a) Inhibition rate of different dose-concentration-time (24, 48, 72 h) of 5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles on squamous cell carcinoma-15 cells. (b) Inhibition rate of different dose-concentration-time (24, 48, 72 h) of α-tocopherol-5-fluorouracil-poly-D,L-lactic-co-glycolic acid nanoparticles on squamous cell carcinoma-15 cells